关联交易
Search documents
华发股份: 华发股份第十届董事局第五十五次会议决议公告
Zheng Quan Zhi Xing· 2025-05-13 10:42
股票代码:600325 股票简称:华发股份 公告编号:2025-045 并同意提呈公司股东大会审议。 珠海华发实业股份有限公司 第十届董事局第五十五次会议决议公告 本公司董事局及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内 容的真实性、准确性和完整性承担法律责任。 珠海华发实业股份有限公司(以下简称"公司")第十届董事局第五十五次会 议通知于 2025 年 5 月 9 日以电子邮件方式发出,会议于 2025 年 5 月 13 日以通 讯方式召开,会议符合《公司法》和《公司章程》的有关规定。经与会董事以通 讯方式表决,形成如下决议: 一、以八票赞成、零票反对、零票弃权审议通过了《关于续签 <金融服务协> 议>暨关联交易的议案》。本项议案已经公司第十届董事局独立董事专门会议 局第五十五次会议审议。本项议案涉及关联交易,关联董事李光宁、郭凌勇、谢 伟、郭瑾、许继莉、张延回避表决。具体内容详见公司同日在上海证券交易所网 站(www.sse.com.cn)及《上海证券报》 《中国证券报》 《证券时报》 《证券日报》 披露的公告(公告编号:2025-046)。 董事局 二、以八票赞成、零票反 ...
音飞储存: 音飞储存2024年年度股东大会会议资料
Zheng Quan Zhi Xing· 2025-05-13 10:21
Meeting Details - The annual general meeting of Nanjing Yinfly Storage Equipment (Group) Co., Ltd. is scheduled for May 2025, with voting available from 9:15 to 15:00 on the day of the meeting [1] - The meeting will be held at the company's conference room located at 470 Yinhua Street, Nanjing Jiangning Economic and Technological Development Zone [1] - The meeting will combine on-site and online voting methods [1] Shareholder Rights and Participation - Shareholders, including proxies, have the right to speak, inquire, and vote during the meeting [2] - Shareholders wishing to speak must register before the meeting starts and should keep their comments concise and relevant to the agenda [2][3] - Voting can be conducted either on-site or online, but shareholders must choose one method [3][4] Board of Directors' Report - The board consists of 7 members, including 4 non-independent and 3 independent directors [4] - Key changes in the board include resignations and subsequent elections of new directors [4][5] - The board has held multiple meetings to discuss various operational and strategic matters, including the appointment of executives and amendments to the company’s articles of association [6] Financial Performance - The company reported a total revenue of approximately CNY 1.44 billion for 2024, a decrease of 8.25% compared to the previous year [15] - The net profit attributable to shareholders was approximately CNY 50.35 million, reflecting a decline of 64.54% year-on-year [16] - The total assets of the company were reported at approximately CNY 3.06 billion, a decrease of 0.98% from the previous year [15] Profit Distribution Proposal - The board proposed a cash dividend of CNY 0.52 per share, totaling approximately CNY 15.3 million to be distributed to shareholders [17] - The proposal aims to maintain the company's tradition of annual cash dividends since its listing [17] Credit Facility Proposal - The company plans to apply for a comprehensive credit facility of up to CNY 2.8 billion from financial institutions for operational needs [18] - The management is authorized to decide on the specifics of the loans within the approved credit limit [18] Supervisory Board Report - The supervisory board has conducted regular meetings and oversight of the company's operations, ensuring compliance with legal and regulatory requirements [10][11] - The board has expressed confidence in the company's financial management and internal controls, noting no significant issues [12][13]
中国瑞林: 2024年度股东大会会议材料
Zheng Quan Zhi Xing· 2025-05-13 09:15
Core Viewpoint - The company is preparing for its 2024 Annual General Meeting (AGM) scheduled for May 19, 2025, focusing on various proposals including financial reports, compensation plans, and governance matters [1][2][3]. Group 1: Meeting Proposals - Proposal 1 includes the confirmation of the 2024 Board of Directors' work report, highlighting a revenue of CNY 2,475.60 million, a decrease of 13.63% compared to the previous year, while net profit attributable to shareholders increased by 2.62% to CNY 152.02 million [4][5][6]. - Proposal 2 addresses the 2024 Supervisory Board work report, emphasizing the board's compliance with legal regulations and its role in safeguarding shareholder interests [15][16]. - Proposal 3 presents the 2024 financial settlement report, which has been audited and reflects the company's financial status accurately [19][20]. Group 2: Financial Performance - The company reported a total asset of CNY 5,196.01 million and a liability of CNY 3,304.10 million, resulting in a debt-to-asset ratio of 63.59% [6][20]. - The operating income for 2024 was CNY 2,475.60 million, with a net cash flow from operating activities of CNY 172.46 million, down 13.63% from the previous year [20][22]. - The company plans to distribute CNY 60 million in cash dividends, representing 39.47% of the net profit attributable to shareholders [27][28]. Group 3: Governance and Compliance - The company has established a governance structure that complies with the Company Law and Securities Law, ensuring transparency and accountability in its operations [10][15]. - The Supervisory Board conducted five meetings during the reporting period, ensuring that all decisions made by the Board of Directors were in line with legal requirements [15][16]. - The company intends to continue its relationship with Tianjian Accounting Firm for the 2025 audit, ensuring ongoing compliance and oversight [30].
阳光诺和拟买朗研生命复牌跌3.6% 标的去年增利降收
Zhong Guo Jing Ji Wang· 2025-05-13 07:25
Core Viewpoint - Sunshine Nuohong (688621.SH) has resumed trading and announced a plan to acquire 100% equity of Langyan Life from its shareholders through the issuance of shares and convertible bonds, alongside raising matching funds from specific investors [1][2]. Group 1: Transaction Details - The company plans to issue shares at a price not lower than 80% of the average trading price of its stock over the previous 120 trading days, which is set at 34.05 yuan per share [2]. - The issuance of convertible bonds will also be priced at 34.05 yuan per share, with a face value of 100 yuan per bond [2]. - The total amount of matching funds raised will not exceed 100% of the transaction price for the asset purchase, with the number of shares issued not exceeding 30% of the company's total share capital prior to the transaction [3]. Group 2: Financial Information of Langyan Life - As of the end of 2024, Langyan Life has total assets of 1,126.87 million yuan and total liabilities of 403.96 million yuan [5][7]. - The company reported revenues of 465.08 million yuan in 2023 and 431.47 million yuan in 2024, with net profits of 36.17 million yuan and 54.39 million yuan for the respective years [5][9]. - The equity attributable to the parent company increased from 640.54 million yuan in 2023 to 703.10 million yuan in 2024 [7]. Group 3: Company Structure and Control - The transaction is classified as a related party transaction, as Langyan Life is controlled by the company's major shareholder, Li Quan [4]. - The company’s total share capital is 112 million shares, with Li Quan holding 30.90 million shares, representing 27.59% of the total [3]. - The transaction is not expected to change the control of the company [4].
泰和新材: 关于向控股子公司增资暨关联交易的公告
Zheng Quan Zhi Xing· 2025-05-12 14:15
临时公告:2025-036 证券代码:002254 股票简称:泰和新材 公告编号:2025-036 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚假记载、误导 性陈述或重大遗漏。 重要内容提示: 司烟台泰和电池新材料科技有限公司(以下简称"泰和电新")、烟台泰和乐彩纺 织科技有限公司(以下简称"泰和乐彩")因经营发展需要,拟进行增资扩股。公 司拟出资人民币 4,698 万元认购泰和电新新增注册资本 4,698 万元,拟出资人民币 合并报表范围变更。 一、关联交易概述 因经营发展需要,公司控股子公司泰和电新、泰和乐彩拟进行增资扩股,其中 泰和电新注册资本拟由人民币 5,000 万元增加到 10,000 万元,泰和乐彩注册资本拟 由人民币 4,036.60 万元增加到 7,036.60 万元。公司拟出资人民币 4,698 万元认购泰 和电新新增注册资本 4,698 万元,泰和电新的其他股东拟出资人民币 302 万元认购 泰和电新新增注册资本 302 万元,增资完成后,公司(含公司全资子公司)对泰和 电新的持股比例上升为 79.98%;公司拟出资人民币 3,000 万元认购泰和乐彩新增注 册资本 ...
亚星化学: 潍坊亚星化学股份有限公司关于变更向控股股东借款金额暨关联交易的公告
Zheng Quan Zhi Xing· 2025-05-12 14:06
Core Viewpoint - Company intends to increase the borrowing limit from its controlling shareholder, Weifang Urban Construction Development Investment Group Co., Ltd., from RMB 200 million to RMB 250 million, with an annual interest rate of 6.9% [1][2]. Summary of Related Sections 1. Basic Information on Related Transactions - The board of directors approved the proposal to borrow from the controlling shareholder on February 21, 2025, and it was subsequently approved at the second extraordinary general meeting on March 11, 2025 [1][3]. 2. Details of the Borrowing Arrangement - The borrowing limit increase was agreed upon after considering the company's financial status and future plans, with all other borrowing conditions remaining unchanged [2][3]. 3. Background on the Controlling Shareholder - Weifang Urban Construction Development Investment Group is the controlling shareholder of the company, established on September 22, 2016, with a registered capital of RMB 500 million [3][4]. 4. Financial Indicators of the Controlling Shareholder - Recent financial indicators of Weifang Urban Construction Development Investment Group were not provided in the document [5]. 5. Purpose and Impact of the Related Transaction - The transaction aims to meet the funding needs for new project construction and mitigate operational risks, without requiring collateral from the company's assets [6]. 6. Approval Process for the Related Transaction - The board of directors and independent directors reviewed and approved the borrowing proposal, ensuring that related directors abstained from voting [6].
兴源环境: 关于公司与特定对象签署《附生效条件的股份认购协议》暨关联交易的公告
Zheng Quan Zhi Xing· 2025-05-12 13:31
Core Viewpoint - The company, Xingyuan Environment Technology Co., Ltd., has signed a conditional share subscription agreement with a related party, Ningbo Jinpeng Intelligent Technology Co., Ltd., to issue A-shares, aiming to raise up to RMB 496.8 million for working capital and debt repayment [1][9]. Group 1: Transaction Overview - The company plans to issue A-shares to Ningbo Jinpeng Intelligent Technology Co., Ltd. for a total amount not exceeding RMB 496.8 million, with a subscription price of RMB 2.07 per share, which is 80% of the average trading price over the previous 20 trading days [1][4]. - The number of shares to be subscribed by Jinpeng Technology will not exceed 240 million shares, accounting for 30% of the company's total share capital prior to the issuance [1][2]. Group 2: Related Party Information - Ningbo Jinpeng Intelligent Technology Co., Ltd. is the controlling shareholder of the company, and this transaction is classified as a related party transaction under the Shenzhen Stock Exchange rules [2][9]. - The company’s board of directors and independent directors have approved the transaction, which still requires approval from the shareholders' meeting, with related shareholders abstaining from voting [2][10]. Group 3: Subscription Agreement Details - The subscription agreement includes provisions for the adjustment of the subscription price in case of capital changes, such as cash dividends or stock splits [4][5]. - The shares subscribed by Jinpeng Technology will be locked for 18 months post-issuance, and any derived shares from stock dividends will also be subject to the same lock-up period [6][7]. Group 4: Purpose and Impact - The transaction aims to enhance the company's production capacity and competitiveness, strengthen its capital base, and support long-term operational development [9][10]. - The funds raised will contribute to the company's sustainable development and align with the interests of all shareholders [9].
华纳药厂: 关于与特定对象签署附条件生效的股份认购协议之补充协议暨关联交易的公告
Zheng Quan Zhi Xing· 2025-05-12 12:25
证券代码:688799 证券简称:华纳药厂 公告编号:2025-050 湖南华纳大药厂股份有限公司 关于与特定对象签署附条件生效的股份认购协议之 补充协议暨关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示: ? 湖南华纳大药厂股份有限公司(以下简称"华纳药厂"、"公司"或"发 行人")拟向特定对象发行 A 股股票(以下简称"本次发行"),鉴于公司对本 次发行方案进行了调整,2025 年 5 月 12 日,公司与湖南华纳至臻产业投资合伙 企业(有限合伙)(以下简称"华纳至臻")签署了《附条件生效的股份认购 协议补充协议(一)》:华纳至臻同意以现金方式认购公司本次向特定对象发 行的股票,认购金额为不超过 25,000.00 万元(含本数)。 营业执照依法自主开展经营活动) 截至本公告出具日,华纳至臻的出资结构如下: 序号 合伙人姓名 合伙人性质 认缴出资额(万元) 出资比例(%) 合计 1,000.00 100.00 截至本公告出具日,华纳至臻除参与本次向特定对象发行股票外,尚未实 际开展其他业务。 ...
热景生物: 北京市康达律师事务所关于北京热景生物技术股份有限公司2025年第二次临时股东大会的法律意见书
Zheng Quan Zhi Xing· 2025-05-12 11:22
北京市朝阳区建外大街丁 12 号英皇集团中心 8、9、11 层 电话/Tel.: 010-50867666 传真/Fax: 010-56916450 网址/Website: www.kangdalawyers.com 北京市康达律师事务所 关于北京热景生物技术股份有限公司 法律意见书 康达股会字【2025】第 0126 号 二〇二五年五月 北京 西安 深圳 海口 上海 广州 杭州 沈阳 南京 天津 菏泽 成都 苏州 呼和浩特 香港 武 汉 郑州 长沙 厦门 重庆 合肥 宁波 济南 昆明 法律意见书 北京市康达律师事务所 关于北京热景生物技术股份有限公司 康达股会字【2025】第0126号 致:北京热景生物技术股份有限公司 根据《中华人民共和国公司法》 (以下简称"《公司法》")、 《中华人民共和国证券 法》 (以下简称"《证券法》")、 《上市公司股东大会规则》 (以下简称"《规则》")、 《北 京热景生物技术股份有限公司章程》 (以下简称"《公司章程》")及北京热景生物技术 股份有限公司(以下简称"公司")与北京市康达律师事务所(以下简称"本所")签 订的法律顾问协议,本所律师对公司 2025 年第二次临时 ...